Physician profile
Steven Han
NPI 1013033190
$1,728.23
in general payments reported to CMS, 2019-2025
20 companies · $89.72 in 2025
The $89.72 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488 · 2020: $203 · 2021: $21.93 · 2023: $800 · 2024: $125 · 2025: $89.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $800 · Food and Beverage: $200 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $800.00 |
| Food and Beverage | $199.72 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verathon INC. | $800.00 | 2023 | Npd Clinical Study |
| Coloplast Corp | $205.31 | 2019-2024 | |
| Astellas Pharma US INC | $110.39 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $88.35 | 2019-2020 | |
| Tempus Ai, INC | $74.72 | 2025 | Xt Cdx |
| 180 Medical, INC. | $74.02 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $46.14 | 2019 | |
| Travere Therapeutics, INC. | $43.90 | 2019-2021 | |
| Rochester Medical Corporation | $35.44 | 2020 | |
| Janssen Biotech, INC. | $34.65 | 2019 | |
| Kaleo, INC. | $34.64 | 2019 | |
| Boston Scientific Corporation | $33.49 | 2019 | |
| Endo Pharmaceuticals INC. | $28.91 | 2019 | |
| Convatec INC. | $26.90 | 2019 | |
| Allergan, INC. | $21.52 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $18.11 | 2021 | |
| Becton, Dickinson and Company | $15.00 | 2025 | Bard X-Force Balloon Dilation Catheter |
| Optinose US, INC. | $13.21 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $11.86 | 2019 | |
| Dentsply Ih INC. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Han listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.